Total Payments
$502,473
2024 Payments
$37,945
Companies
20
Transactions
388
Medicare Patients
60
Medicare Billing
$7,904
Payment Breakdown by Category
Research$219,433 (43.7%)
Other$148,984 (29.7%)
Consulting$102,089 (20.3%)
Travel$21,726 (4.3%)
Food & Beverage$10,231 (2.0%)
Education$10.70 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $219,433 | 23 | 43.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $107,480 | 36 | 21.4% |
| Consulting Fee | $102,089 | 33 | 20.3% |
| Honoraria | $41,504 | 17 | 8.3% |
| Travel and Lodging | $21,726 | 109 | 4.3% |
| Food and Beverage | $10,231 | 169 | 2.0% |
| Education | $10.70 | 1 | 0.0% |
Payments by Type
General
$283,041
365 transactions
Research
$219,433
23 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ADMA BioManufacturing LLC | $220,792 | 34 | $0 (2024) |
| Pharming Healthcare, Inc. | $96,434 | 88 | $0 (2024) |
| Shire North American Group Inc | $95,138 | 153 | $0 (2019) |
| CSL Behring | $46,785 | 52 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $29,487 | 24 | $0 (2023) |
| Chiesi USA, Inc. | $4,224 | 3 | $0 (2024) |
| Grifols Shared Services North America, Inc. | $4,134 | 2 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $2,588 | 1 | $0 (2021) |
| Genentech USA, Inc. | $623.32 | 6 | $0 (2019) |
| Octapharma USA, Inc. | $406.16 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $37,945 | 49 | Pharming Healthcare, Inc. ($33,227) |
| 2023 | $109,234 | 63 | Pharming Healthcare, Inc. ($61,118) |
| 2022 | $17,622 | 16 | CSL Behring ($7,730) |
| 2021 | $191,747 | 28 | ADMA BioManufacturing LLC ($169,253) |
| 2020 | $11,827 | 12 | Takeda Pharmaceuticals U.S.A., Inc. ($9,633) |
| 2019 | $20,007 | 42 | Shire North American Group Inc ($19,200) |
| 2018 | $59,939 | 64 | Shire North American Group Inc ($47,968) |
| 2017 | $54,151 | 114 | Shire North American Group Inc ($27,971) |
All Payment Transactions
388 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Pharming Healthcare, Inc. | — | Consulting Fee | Cash or cash equivalent | $5,850.00 | General |
| 11/21/2024 | Chiesi USA, Inc. | REVCOVI (Drug) | Honoraria | Cash or cash equivalent | $4,138.86 | General |
| Category: ERT FOR ADA-SCID | ||||||
| 11/21/2024 | Chiesi USA, Inc. | REVCOVI (Drug) | Food and Beverage | Cash or cash equivalent | $64.36 | General |
| Category: ERT FOR ADA-SCID | ||||||
| 11/21/2024 | Chiesi USA, Inc. | REVCOVI (Drug) | Travel and Lodging | Cash or cash equivalent | $20.70 | General |
| Category: ERT FOR ADA-SCID | ||||||
| 11/12/2024 | Pharming Healthcare, Inc. | — | Food and Beverage | In-kind items and services | $56.81 | General |
| 11/11/2024 | Pharming Healthcare, Inc. | — | Travel and Lodging | In-kind items and services | $1,160.48 | General |
| 11/11/2024 | Pharming Healthcare, Inc. | — | Travel and Lodging | In-kind items and services | $505.04 | General |
| 11/11/2024 | Pharming Healthcare, Inc. | — | Travel and Lodging | In-kind items and services | $491.96 | General |
| 11/11/2024 | Pharming Healthcare, Inc. | — | Food and Beverage | In-kind items and services | $125.68 | General |
| 11/11/2024 | Pharming Healthcare, Inc. | — | Food and Beverage | In-kind items and services | $21.58 | General |
| 11/10/2024 | Pharming Healthcare, Inc. | JOENJA (Drug) | Food and Beverage | In-kind items and services | $96.08 | General |
| Category: APDS | ||||||
| 11/09/2024 | Pharming Healthcare, Inc. | JOENJA (Drug) | Food and Beverage | In-kind items and services | $55.08 | General |
| Category: APDS | ||||||
| 11/09/2024 | Pharming Healthcare, Inc. | JOENJA (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: APDS | ||||||
| 11/09/2024 | Pharming Healthcare, Inc. | JOENJA (Drug) | Travel and Lodging | In-kind items and services | $6.45 | General |
| Category: APDS | ||||||
| 11/08/2024 | Pharming Healthcare, Inc. | JOENJA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: APDS | ||||||
| 11/08/2024 | Pharming Healthcare, Inc. | JOENJA (Drug) | Travel and Lodging | In-kind items and services | $1,752.35 | General |
| Category: APDS | ||||||
| 11/08/2024 | Pharming Healthcare, Inc. | JOENJA (Drug) | Food and Beverage | In-kind items and services | $49.09 | General |
| Category: APDS | ||||||
| 11/08/2024 | Pharming Healthcare, Inc. | JOENJA (Drug) | Food and Beverage | In-kind items and services | $33.86 | General |
| Category: APDS | ||||||
| 11/08/2024 | Pharming Healthcare, Inc. | JOENJA (Drug) | Travel and Lodging | In-kind items and services | $20.00 | General |
| Category: APDS | ||||||
| 11/08/2024 | Pharming Healthcare, Inc. | JOENJA (Drug) | Travel and Lodging | In-kind items and services | $15.60 | General |
| Category: APDS | ||||||
| 11/07/2024 | Pharming Healthcare, Inc. | JOENJA (Drug) | Travel and Lodging | In-kind items and services | $695.40 | General |
| Category: APDS | ||||||
| 11/07/2024 | Pharming Healthcare, Inc. | JOENJA (Drug) | Food and Beverage | In-kind items and services | $75.81 | General |
| Category: APDS | ||||||
| 11/07/2024 | Pharming Healthcare, Inc. | JOENJA (Drug) | Travel and Lodging | In-kind items and services | $75.00 | General |
| Category: APDS | ||||||
| 11/07/2024 | Pharming Healthcare, Inc. | JOENJA (Drug) | Travel and Lodging | In-kind items and services | $15.00 | General |
| Category: APDS | ||||||
| 10/30/2024 | Pharming Healthcare, Inc. | JOENJA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: APDS | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Multicenter, Non-interventional, Observational, Prospective Study to Assess Hypotension in Patients With Primary Immunodeficiency Disease Treated With Bivigam (Human 10%) or Other Commercial Human 10% Immune Globulin (Intravenous) (IGIV) Products During Infusion and up to 72 Hours Post Infusion (Pass 17) | ADMA BioManufacturing LLC | $169,229 | 12 |
| A Phase IV, Multicenter, Open-label Study to Evaluate the Safety and Pharmacokinetics of BIVIGAM in Primary Immune Deficiency Disorders in Subjects Aged 2 to 16 | ADMA BioManufacturing LLC | $3,840 | 3 |
| LE 3301 | Pharming Healthcare, Inc. | $2,100 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 14 | 17 | $6,510 | $1,582 |
| 2022 | 1 | 16 | 22 | $8,513 | $2,248 |
| 2021 | 1 | 18 | 24 | $8,840 | $2,528 |
| 2020 | 1 | 12 | 13 | $5,720 | $1,546 |
Total Patients
60
Total Services
76
Medicare Billing
$7,904
Procedure Codes
4
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 17 | $6,510 | $1,582 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 16 | 22 | $8,513 | $2,248 | 26.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 24 | $8,840 | $2,528 | 28.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 12 | 13 | $5,720 | $1,546 | 27.0% |
About Dr. Jolan Walter, M.D
Dr. Jolan Walter, M.D is a Allergy & Immunology healthcare provider based in St Petersburg, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1467649525.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jolan Walter, M.D has received a total of $502,473 in payments from pharmaceutical and medical device companies, with $37,945 received in 2024. These payments were reported across 388 transactions from 20 companies. The most common payment nature is "" ($219,433).
As a Medicare-enrolled provider, Walter has provided services to 60 Medicare beneficiaries, totaling 76 services with total Medicare billing of $7,904. Data is available for 4 years (2020–2023), covering 4 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Other Specialties Pediatric Allergy/Immunology
- Location St Petersburg, FL
- Active Since 10/02/2007
- Last Updated 10/27/2020
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1467649525
Products in Payments
- Bivigam (Drug) $194,161
- JOENJA (Drug) $79,077
- CUVITRU (Biological) $52,836
- CINRYZE (Drug) $42,743
- Hizentra (Biological) $40,718
- Asceniv (Drug) $23,172
- HYQVIA (Biological) $21,767
- REVCOVI (Drug) $4,224
- Gamunex-C (Biological) $4,206
- Privigen (Biological) $1,560
- RUCONEST (Biological) $495.68
- Xolair (Biological) $473.33
- CUTAQUIG (Biological) $406.16
- FASENRA (Drug) $276.61
- Xembify (Biological) $271.19
- Haegarda (Biological) $247.92
- DUPIXENT (Biological) $242.36
- Revcovi (Drug) $229.47
- COSENTYX (Biological) $120.81
- DUPIXENT DUPILUMAB INJECTION (Biological) $115.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.